A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders
Aim: To assess microbial contamination of 20% autologous serum (AS) eye drops used in a hospital inpatient setting. Method: 14 patients received autologous serum drops from 4 to 14 days with a cumulative total of 67 days. For each day the first and last drop (total 134 samples) was cultured on broth...
Saved in:
Published in: | British journal of ophthalmology Vol. 88; no. 4; pp. 464 - 465 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01-04-2004
BMJ BMJ Publishing Group LTD Copyright 2004 British Journal of Ophthalmology |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aim: To assess microbial contamination of 20% autologous serum (AS) eye drops used in a hospital inpatient setting. Method: 14 patients received autologous serum drops from 4 to 14 days with a cumulative total of 67 days. For each day the first and last drop (total 134 samples) was cultured on broth and blood agar. Results: Four patients (9 samples) grew Staphylococcus epidermidis only. One patient (1 sample) showed Staphylococcus epidermidis and a scanty growth of viridans streptococci in the same sample, and on different days the same patient grew Staphylococcus aureus in one sample and Staphylococcus epidermidis in another sample. One patient (1 sample) grew micrococcus. There was no clinical or microbial evidence of infection in any of these six patients Conclusion: This study shows that autologous serum drops can be safely used in an inpatient setting, under a strict protocol of preparation and storage, without significant risk of bacterial contamination and consequent infection. |
---|---|
Bibliography: | local:0880464 istex:F7ABEE8CD36DC3F33E479C7FFFAAAE4C9E96F290 href:bjophthalmol-88-464.pdf PMID:15031155 Correspondence to: Professor H S Dua Division of Ophthalmology and Visual Sciences, B Floor, Eye Ear Nose Throat Centre, University Hospital, Queens Medical Centre, Nottingham NG7 2UH, UK; harminder.dua@nottingham.ac.uk ark:/67375/NVC-1DXPG18B-K ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Professor H S Dua Division of Ophthalmology and Visual Sciences, B Floor, Eye Ear Nose Throat Centre, University Hospital, Queens Medical Centre, Nottingham NG7 2UH, UK; harminder.dua@nottingham.ac.uk Commercial relationships of authors: none. Ruby Lagnado was the Vision Express Fellow, Corneal and Contact Lenses, University of Nottingham. |
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjo.2003.025528 |